文献速递肿瘤 PET/CT

18F-FDG PET/CT或可预测妊娠滋养细胞疾病的肿瘤类型与风险评分

18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease.
PubMed 文献 · Clin Nucl Med · 2022-03-30

本研究回顾性纳入24例妊娠滋养细胞疾病(GTD)分期患者,探讨18F-FDG PET/CT半定量参数预测肿瘤类型和FIGO评分风险分组的价值。SUVmax和SUVmean对肿瘤类型有预测价值,TLG对风险分层有预测价值。

要点

  • SUVmax和SUVmean对GTD肿瘤类型有预测价值,AUC分别为0.783和0.811。
  • TLG对基于FIGO评分的风险分层有预测价值,AUC为0.770。
  • 18F-FDG PET参数在预测GTD病理预后因素方面有作用。

核心结论

  • 18F-FDG PET参数在预测GTD病理预后因素方面有作用,SUVmax和SUVmean可预测肿瘤类型,TLG可预测风险分层。

研究设计与样本

  • 回顾性单中心研究,纳入2005年5月至2021年3月因GTD分期目的接受18F-FDG PET/CT的24例连续患者。
  • 从原发肿瘤测量SUVmax、SUVmean、代谢性肿瘤体积(MTV)和总病灶糖酵解(TLG)用于分析。

主要发现

  • SUVmax对肿瘤类型(非葡萄胎滋养细胞肿瘤 vs 葡萄胎后滋养细胞肿瘤)为一般预测因子(AUC 0.783;95%CI 0.56-0.95),呈低度相关(ρ=0.489,校正P=0.030)。
  • SUVmean对肿瘤类型为良好预测因子(AUC 0.811;95%CI 0.59-0.97),呈中度相关(ρ=0.538,校正P=0.027)。
  • 根据FIGO评分,TLG为患者风险分层的一般预测因子(AUC 0.770;95%CI 0.50-0.99)。

关键数值与推荐

  • SUVmax预测肿瘤类型:AUC 0.783(95%CI 0.56-0.95),ρ=0.489,校正P=0.030。
  • SUVmean预测肿瘤类型:AUC 0.811(95%CI 0.59-0.97),ρ=0.538,校正P=0.027。
  • TLG预测FIGO评分风险分层:AUC 0.770(95%CI 0.50-0.99)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to investigate the role of 18F-FDG PET/CT in predicting pathological prognostic factors, including tumor type and International Federation of Gynecology and Obstetrics (FIGO) score, in gestational trophoblastic disease (GTD). METHODS: Retrospective monocentric study including 24 consecutive patients who underwent to 18F-FDG PET/CT from May 2005 to March 2021 for GTD staging purpose. The following semiquantitative PET parameters were measured from the primary tumor and used for the analysis: maximum standardized uptake value (SUVmax), SUVmean, metabolic tumor volume (MTV) and total lesion glycolisis (TLG). Statistical analysis included Spearman correlation coefficient to evaluate the correlations between imaging parameters and tumor type (nonmolar trophoblastic vs postmolar trophoblastic tumors) and risk groups (high vs low, defined according to the FIGO score), whereas area under the curve (AUC) of the receiver operating characteristic (ROC) curve was used to assess the predictive value of the PET parameters. Mann-Whitney U test was used to further describe the parameter's potential in differentiating the populations. RESULTS: SUVmax and SUVmean resulted fair (AUC, 0.783; 95% confidence interval [CI], 0.56-0.95) and good (AUC, 0.811; 95% CI, 0.59-0.97) predictors of tumor type, respectively, showing a low (ρ = 0.489, adjusted P = 0.030) and moderate (ρ = 0.538, adjusted P = 0.027) correlation. According to FIGO score, TLG was instead a fair predictor (AUC, 0.770; 95% CI, 0.50-0.99) for patient risk stratification. CONCLUSIONS: 18F-FDG PET parameters have a role in predicting GTD pathological prognostic factors, with SUVmax and SUVmean being predictive for tumor type and TLG for risk stratification.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Bezzi C, Monaco L, Ghezzo S, et al. 18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease. Clin Nucl Med. 2022. PMID: 35353763. doi:10.1097/RLU.0000000000004135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。